Isotretinoin-associated pseudoporphyria.
We present two patients who developed pseudoporphyria whilst taking isotretinoin (Roaccutane). At that time, both patients were receiving other agents which could be incriminated as causing their pseudoporphyria. However, it is significant that these other agents had been longstanding and that the p...
| Үндсэн зохиолчид: | , , |
|---|---|
| Формат: | Journal article |
| Хэл сонгох: | English |
| Хэвлэсэн: |
1993
|
| _version_ | 1826274659146924032 |
|---|---|
| author | Riordan, C Anstey, A Wojnarowska, F |
| author_facet | Riordan, C Anstey, A Wojnarowska, F |
| author_sort | Riordan, C |
| collection | OXFORD |
| description | We present two patients who developed pseudoporphyria whilst taking isotretinoin (Roaccutane). At that time, both patients were receiving other agents which could be incriminated as causing their pseudoporphyria. However, it is significant that these other agents had been longstanding and that the porphyria-like cutaneous changes did not develop until after the introduction of the isotretinoin (Roaccutane). In both cases, withdrawal of the isotretinoin resulted in clinical improvement of their cutaneous signs. The interaction of isotretinoin and another agent, rather than isotretinoin independently, may be involved in the development of pseudoporphyria. |
| first_indexed | 2024-03-06T22:46:48Z |
| format | Journal article |
| id | oxford-uuid:5d75a99c-b2e2-4e02-ab6c-6c49646519f8 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:46:48Z |
| publishDate | 1993 |
| record_format | dspace |
| spelling | oxford-uuid:5d75a99c-b2e2-4e02-ab6c-6c49646519f82022-03-26T17:34:36ZIsotretinoin-associated pseudoporphyria.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5d75a99c-b2e2-4e02-ab6c-6c49646519f8EnglishSymplectic Elements at Oxford1993Riordan, CAnstey, AWojnarowska, FWe present two patients who developed pseudoporphyria whilst taking isotretinoin (Roaccutane). At that time, both patients were receiving other agents which could be incriminated as causing their pseudoporphyria. However, it is significant that these other agents had been longstanding and that the porphyria-like cutaneous changes did not develop until after the introduction of the isotretinoin (Roaccutane). In both cases, withdrawal of the isotretinoin resulted in clinical improvement of their cutaneous signs. The interaction of isotretinoin and another agent, rather than isotretinoin independently, may be involved in the development of pseudoporphyria. |
| spellingShingle | Riordan, C Anstey, A Wojnarowska, F Isotretinoin-associated pseudoporphyria. |
| title | Isotretinoin-associated pseudoporphyria. |
| title_full | Isotretinoin-associated pseudoporphyria. |
| title_fullStr | Isotretinoin-associated pseudoporphyria. |
| title_full_unstemmed | Isotretinoin-associated pseudoporphyria. |
| title_short | Isotretinoin-associated pseudoporphyria. |
| title_sort | isotretinoin associated pseudoporphyria |
| work_keys_str_mv | AT riordanc isotretinoinassociatedpseudoporphyria AT ansteya isotretinoinassociatedpseudoporphyria AT wojnarowskaf isotretinoinassociatedpseudoporphyria |